Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 6/20 | 0.46 |
| ▸ | CNR1 | P21554 | 4/20 | 0.46 |
| ▸ | CNR2 | P34972 | 4/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.44 |
| ▸ | TLR4 | O00206 | 3/20 | 0.40 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.39 |
| ▸ | NEU2 | Q9Y3R4 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5546177 | 1.00 | TRPV1 (0.46) | TRPV1CNR1CNR2AKT1TLR4 | |
| SCHEMBL5546192 | 0.99 | TRPV1 (0.43) | TRPV1CNR1CNR2AKT1TLR4 | |
| SCHEMBL5545013 | 0.89 | PYGB (0.42) | TRPV1CNR1CNR2AKT1NEU1 | |
| SCHEMBL5540221 | 0.86 | PAX8 (0.45) | TRPV1CNR1CNR2AKT1NEU1 | |
| SCHEMBL5545047 | 0.85 | TRPV1 (0.42) | TRPV1CNR1CNR2FAAH | |
| SCHEMBL5538106 | 0.85 | TRPV1 (0.42) | TRPV1CNR1CNR2FAAH | |
| SCHEMBL22431121 | 0.81 | PYGB (0.51) | TRPV1CNR1CNR2TLR4 | |
| SCHEMBL22431363 | 0.81 | PYGB (0.51) | TRPV1CNR1CNR2TLR4 | |
| SCHEMBL5544908 | 0.78 | PAX8 (0.42) | TRPV1CNR1CNR2 | |
| SCHEMBL7392756 | 0.78 | TRPV1 (0.48) | TRPV1CNR1CNR2TLR4HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8951961-B2 | Structural and mechanistic basis for novel compound biosynthesis using 4-electron hexose oxidase | ACADEMIA SINICA (TW) | 2015-02-10 | — | — | US | disclosed |
| US-20130288955-A1 | STRUCTURAL AND MECHANISTIC BASIS FOR NOVEL COMPOUND BIOSYNTHESIS USING 4-ELECTRON HEXOSE OXIDASE | ACADEMIA SINICA (TW) | 2013-10-31 | — | — | US | disclosed |
| US-8507427-B2 | Structural and mechanistic basis for novel compound biosynthesis using the 4-electron hexose oxidase | ACADEMIA SINICA (TW) | 2013-08-13 | — | — | US | disclosed |
| US-20120108498-A1 | STRUCTURAL AND MECHANISTIC BASIS FOR NOVEL COMPOUND BIOSYNTHESIS USING THE 4-ELECTRON HEXOSE OXIDASE | ACADEMIA SINICA (TW) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108498-A1 | STRUCTURAL AND MECHANISTIC BASIS FOR NOVEL COMPOUND BIOSYNTHESIS USING THE 4-ELECTRON HEXOSE OXIDASE | G6PD, DHRS9, CYP2C9 | TRPV1 2816/4885CNR1 2667/4885CNR2 2538/4885 |
| US-20130288955-A1 | STRUCTURAL AND MECHANISTIC BASIS FOR NOVEL COMPOUND BIOSYNTHESIS USING 4-ELECTRON HEXOSE OXIDASE | G6PD, CYP4X1, UGT1A9 | TRPV1 2482/4885CNR1 2657/4885CNR2 2549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.